Abstract:The purpose of this study was to report experience of Department of Oromaxillofacial-Head and Neck Surgery, Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University in the treatment of ameloblastoma in children and young people and to discuss the treatment regimen. And review the world literature on the treatment of ameloblastoma in children and adolescents from 1986.A total of 227 patients were recorded of which, 30 (13.21%) were below the age of 18 years, with a diagnosis of ameloblastoma in our hospital between January 1994 to June 2011. The study included the patient's age, gender, lesion location, clinical features, radiographic appearance, treatment, recurrences and course of follow-up.30 cases of children and adolescents ameloblastoma patients, 19 males and 11 females, male to female ratio was 1.7:1, the average age of 14.5 years. 28 cases of lesions in the mandible, only 2 cases occurred in the maxilla. Clinical typing included 21(70%) solid type and 9(30%) unicystic type. 7 (23.33%) patients were treated with radical treatment, 23 (76.67%) cases underwent conservative method. 7 (23.33%) cases were recurrent, of which 6 cases of recurrence once, and 1 patient had 2 recurrences. Desired results can be reached in the treatment of ameloblastoma in children and adolescents using conservative measure, and can reduce the incidence of maxillofacial deformity and dysfunction. Determine the treatment required to consider many factors. Patient compliance and complete follow-up are important.
Introduction
Ameloblastoma is a common benign but locally aggressive odontogenic tumor of the jaw known for high rates of recurrence.
It accounts for approximately 60% of odontogenic tumors of the mandible and 10% of all jaw tumors 1) . Falkson first described Ameloblastoma in 1879. It was officially named ameloblastoma by Churchill in 1929. The disease has a long course, slow growth, and no early symptoms. In some cases, the slow growth allows the periosteum to form a thin bony shell around the lesion that cracks on palpation, resulting in a characteristic crepitus; this diagnostic feature is known as "egg shell cracking". The expansive growth can cause facial deformity and functional obstacles, such as difficulty opening the mouth, swallowing, chewing, and breathing, as well as pathologic fracture and other complications.
Approximately 10-15% of all ameloblastoma occur in children and adolescents; it is considered a rare tumor in these groups 2) . A conservative surgical approach usually results in a high recurrence rate, but radical surgery may lead to facial deformities. Therefore, treatment of ameloblastoma in children and adolescents remains controversial.
This report reviews 30 cases of ameloblastoma in patients 18
years of age and younger who were treated at a single hospital. It also contains a review and analysis of relevant literature that includes clinical and treatment data published during the past 25 years. The aim of this study is to further the understanding of ameloblastoma in children and adolescents and to recommend appropriate treatment options.
Materials and Methods
Due to the retrospective nature of this study, it was granted an exemption in writing by the China For the literature review, 12 articles regarding the treatment of a total of 317 children and adolescents with ameloblastoma published between 1986 and the present were chosen for review and analysis (Table 2) .
Results
Of 30 patients treated by the authors, there were 19 males and (curettage, decompression surgery), and there were 7 recurrences.
There were no recurrences among 7(23.3%, 5 solid, 2 unicystic) patients who underwent radical surgery (free fibular graft, iliac bone graft cut) as the initial treatment.
The postoperative follow-up period ranged from 6 months to 5 years. Among the 7 patients who developed recurrence, 6 had one recurrence and 1 had two recurrences. There were 17 patients who were followed for 5 years without recurrence. Three patients did not undergo recommended treatment, and were lost to followup after one year.
Discussion
In order to help formulate the most appropriate approach to treatment of ameloblastoma in children and adolescents, the literature from the past 25 years regarding the treatment of ameloblastoma in children and adolescents was reviewed, The male to female ratio in the present study was 1.7:1; this is the same as that reported by Daramola et al 3) , and similar to Zhang . Some authors, including Chidzonga et al 8) and
Takahashi et al 9) have reported male to female ratios of 1:1. In the present study, the incidence rate of ameloblastoma in children and adolescents was 13.2% (30/227 tumors in all age groups). This is similar the incidence of 14.6% reported by Kahn 11) , who reported incidence rates of 21.3% and 21.9%, respectively, in African populations.
In the present study, there were 27 patients (90%) between the ages of 11 and 18 years, and 3 patients (10%) under the age of 11 years. Similarly, in the study by Zhang et al 4) , 8 .1% of the patients were under 11 years old; in Arotiba et al 11) , 7% were under the age of 11. There were no patients under 11years old among the patients reported by Chidzonga et al 8 and Butt et al 10) .
The radiographic appearance of ameloblastoma in children and adolescents can be classified as unilocular or multilocular. In Kahn et al 6) and Huang et al 5) , the majority of tumors were unilocular (68.42% and 66.67%, respectively). This was also true of the present study, in which 60% (18/30) of the patients had unilocular lesions. However, Chidzonga et al 8) and Olaitan and Adekeye 1) reported more patients with multilocular lesions (85% and 76.67% respectively).
Most authors have reported that 12, 13) unilocular tumors have In the literature review portion of the present study, it was noted that in the majority of patients treated in Africa, radical surgery was the initial treatment. In Butt et al 10) It has long been disputed whether ameloblastoma patients need radiotherapy or chemotherapy. Most authors believe that ameloblastoma is not sensitive to radiotherapy or chemotherapy.
For instance, the results of studies by Simko 18) indicated that radiotherapy and chemotherapy in the treatment of ameloblastoma had no significant effect. However, Madhup 19) has maintained that properly administered radiotherapy does have a useful role in the management of these tumors, especially in cases where a complete surgical excision would be technically difficult because of bulk and local invasion or where other factors, such as age, exclude complete excision. In the present study, none of the patients were treated with radiotherapy or chemotherapy.
Conclusions
Because children and adolescents with ameloblastoma are still developing physically and psychologically, various factors must be considered in selecting appropriate treatment. Conservative treatment can get good results, effectively controlling the progression of the disease until maturity allows for complete excision, or even curing the disease, and it can also reduce dysfunction and facial deformity. Good compliance from the patients and their families and regular follow-up are important factors in ensuring successful treatment when the conservative approach is chosen.
